Clinical Trial Update: An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin

View source ↗

Summary

An observational study reported results on predictive factors of response in patients with chronic hepatitis C treated with Pegasys (peginterferon alfa-2a) and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Status: COMPLETED | Results posted: 2015-12-14